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Background and purpose—The classic presentation of chronic (Stage III) hemorrhagic 
stroke lesions is a fluid-filled cavity. In one of the most commonly used animal 
models of intracerebral hemorrhage (ICH), we noticed additional solid material 
within the chronic lesion. We examined the composition of those chronic ICH lesions 
and compared them with human autopsy cases.   
Methods—ICH was induced in rats by the injection of collagenase in the striatum. Tissue 
sections after hematoma resolution corresponding to three different chronic time 
points—28, 42, and 73-85 days post-ICH—were selected. Human autopsy reports at 
the University Hospital of Zurich were searched between 1990 and 2019 for ICH and 
three chronic cases were found. The rat and human sections were stained with a 
variety of histopathological markers.  
Results—Extensive collagenous material was observed in the chronic lesion after 
hematoma resolution in both the rat model and human autopsy cases. Additional 
immunostaining revealed that the material consisted primarily of a loose network of 
collagen 3 intermingled with occasional GFAP-positive processes and collagen 4.  
Conclusions—A key feature of the chronic ICH lesion is a loose network of collagen 3. 
The collagenase rat model reproduces the morphology and composition of the chronic 
human ICH lesion. While identifying new features of ICH lesion pathology, these 
results are important for treatment and recovery strategies. 
 
Nonstandard Abbreviations and Acronyms 
ICH intracerebral hemorrhage 
GFAP glial fibrillary acidic protein 
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NeuN neuronal nuclear protein 
α-SMA alpha smooth muscle actin 
H&E hematoxylin and eosin 
eVG elastic Van Gieson  
 
Introduction 
The evolution of hemorrhagic stroke lesions consists of three stages: deformation, 
edema, and necrosis of the surrounding tissues (Stage I); resorption of the hematoma 
(Stage II); and full resolution of the hematoma resulting in a fluid-filled cavity (Stage 
III).1 In human Stage II lesions, a capsule-like, collagenous border has been observed.2,3 
Histological examination after autologous blood injection in dogs reveals the formation 
of argentophilic fibers on the border of the hematoma with a gradual change to more 
mature collagenous fibers. However, the studies were limited to Stages I and II with the 
hematoma still present.4,5 Prior reports of Stage III hemorrhagic lesions in humans 
describe a thin, fluid-filled cavity that is indistinguishable from a Stage III infarct except 
for the presence of blood-related deposits such as hemosiderin and walls and fluid that 
have a yellow to brown coloration.1,2,6,7  
Histopathological characterization of chronic stroke lesions is important for the 
development of new biomaterial-based therapies8 that physically interact with lesion 
constituents and require a space to accommodate the injection. Development of these 
emerging therapies typically begins in rodent stroke models, but lesion outcomes may be 
species dependent.9 Therefore, histopathological comparison is essential to determine if 
chronic lesions in animal models reproduce the key features found in clinical cases. 
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While developing a biomaterial-based therapy10 for chronic ICH in a collagenase-induced 
rat model11, we noticed that the chronic rat lesions were not a simple fluid-filled cavity as 
expected. Herein, we report on the composition of these lesions and compare them with 
human autopsy cases of chronic ICH.  
 
Methods 
This study adheres to the AHA journals’ implementation of the Transparency and 
Openness Promotion Guidelines; the authors declare that all supporting data are available 
within the article (and in the Data Supplement). Human autopsy reports at the University 
Hospital of Zurich were searched between 1990 and 2019 for ICH and three chronic 
cases (1 male and 2 females) were found. The Executive Director of the Kantonale 
Ethikkommission provided notification that the histopathologic examination of autopsy 
samples did not fall within the scope of the Human Research Act (HRA). Human samples 
consisted of formalin-fixed tissue embedded in paraffin with immunostaining for GFAP, 
collagen 3, collagen 4, NeuN, and α-SMA by standard methods based on the oxidation of 
3,3'-diaminobenzidine.  
The rat model consisted of injection of collagenase (0.1U type VII in 1μL saline) 
into the right striatum of male Sprague-Dawley rats (280-300 grams). All procedures 
were performed in accordance with the Institutional Animal Care and Use Committee of 
Massachusetts General Hospital (animal protocol number 2012N000165) and the Guide 
for Use and Care of Laboratory Animals from the National Institute of Health (NIH). At 
28, 42, and 73-85 days post-ICH, the rats (n=6 per group) were sacrificed and the 
extracted brains were fixed in 4% paraformaldehyde, cryopreserved in 30% sucrose, and 
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frozen. Cryosections (30μm) were immunostained for GFAP, collagen 3, collagen 4, 
NeuN, and α-SMA by standard methods based on a secondary fluorescent antibody.  
Additional experimental details for the human and rat samples are provided in the 
Data Supplement.  
 
Results 
In a well-validated, collagenase-induced rat model of ICH11, we noticed an 
unexpected material inside chronic lesions after hematoma resolution (Figure 1). Further 
staining revealed that the material consisted primarily of collagen 3 intermingled with 
occasional GFAP-positive processes and collagen 4. Collagen 3 is typically associated 
with reticular fibers and forms the loose extracellular matrix found early within a wound 
that heals by coagulative necrosis. There was no significant difference over time in the 
amount of collagen 3 or lesion volume that would indicate wound healing (Figure I in the 
Data Supplement). The formation of a stable, hemorrhagic lesion in rat after hematoma 
resolution (~ 2-3 weeks depending on initial hematoma size) is consistent with prior 
studies.12,13 
At all three examined time points and for reasons that are not yet known, we 
observed two types of lesion morphology: thin, compacted lesions and larger, less dense 
lesions. The collagenous fibers were found within both lesion types (Figure 1). NeuN 
(Figure II in the Data Supplement) and α-SMA (Figure III in the Data Supplement) were 
absent within the lesions at all time points. Negative controls are included in the Data 
Supplement (Figure IV).  
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To check our rat model observations with human outcomes, we searched autopsy 
reports at the University Hospital of Zurich between 1990 and 2019 for ICH and found 
three Stage III cases (Table and Figure V in the Data Supplement). Stage III hemorrhagic 
lesions were not the direct cause of death in any of the patients.  
An unexpected finding was the extensive extracellular matrix (ECM) inside the 
lesion in the H&E stained sections (Figure 2). Subsequent elastic Van Gieson (eVG) 
staining (Figure 2) revealed that most of the material consisted of loosely organized 
collagen fibers (in pink). We performed additional immunostaining, which revealed 
predominantly type 3 collagen (Figure 2). GFAP, non-vascular α-SMA, and NeuN were 
negative within the lesions (Figure VI in the Data Supplement). The lack of pervasive α-
SMA is consistent with the finding of a loose network of collagen 3 in contrast to the 
contracted collagen 1 scar of chronic skin and musculoskeletal lesions. Some 
calcification was observed in the lesion of patient 2. Negative controls are included in the 
Data Supplement (Figure VII).  
Discussion 
We observed extensive collagenous material, primarily collagen 3 with occasional 
GFAP-positive processes and collagen 4, in the chronic lesion after 
hematoma resolution in both the rat model and human autopsy cases. The source of the 
collagen-producing cells is unknown. Proposed sources based on brain and spinal cord 
lesions in rodents include meningeal fibroblasts14, perivascular fibroblasts15, and 
endothelial cells16. The proposed purpose of the collagen in rodent lesions is to provide a 
scaffold for invading fibroblasts, macrophages, and blood vessels.14 In Stage II ICH 
human lesions, we observe a collagen capsule surrounding the hematoma that is distinct 
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from an outer GFAP-positive glial layer, which contains CD68-positive 
microglia/macrophages (Figure VIII in the Data Supplement). This subacute capsule 
consists primarily of collagen 3 (Figure VIII in the Data Supplement); therefore, the 
collagen 3 observed in Stage III lesions might be related to the Stage II capsule.  
We were surprised to find only a few chronic cases of ICH in the archives. 
Perhaps chronic ICH lesions are underrepresented because incidence is lower and acute 
mortality is higher compared to ischemic stroke.17 Nowadays, very few autopsies for ICH 
are performed because they can be diagnosed by neuroimaging. While old microbleeds 
are difficult to detect, we tried looking at cavernous hemangiomas, which are known to 
bleed repeatedly with a prolonged history; however, the distinction between collagen 
associated with atypical vessels and putative bleeding-associated tissue is difficult. 
Further studies of larger numbers of patients would be helpful to confirm our findings 
and expand our understanding of them—such as if they are global or restricted to ICH in 
specific brain regions.  
Despite the very different time of investigation post-ICH of the rat (tens of days) 
and human Stage III lesions (years), they are found with the same morphology and 
composition. Our comparison is based on the end stage of the lesion, and further work is 
needed to determine if these findings are coincidental or related to similarities in 
hematoma resolution with a different time scale based on the initial hematoma size. 
The examination and comparison of chronic stroke lesions in animal models and 
human clinical cases is important for treatment and recovery strategies. The injection of a 
biomaterial-based therapy into a chronic lesion requires space to accommodate the 
biomaterial. The loose, porous collagen 3 matrix that was observed unexpectedly in the 
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chronic rat lesion did not inhibit the subsequent injection of a biomaterial into the 
lesion.10 Presumably, the liquid injection displaces the collagen fibers or infiltrates the 
porous network before gelation in situ. Based on our findings of a similar lesion 
composition in the human cases, we anticipate that chronic human ICH lesions can also 
accommodate and prove amenable to treatment with a biomaterial-based therapy.  
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Figure 1. The main constituent of chronic ICH lesions after hematoma resolution in a 
collagenase-induced rat model is collagen 3. Each row corresponds to a representative 
lesion in the striatum at 28 days (n=6), 42 days (n=6), and 73-85 days (n=6) post-ICH. 
Note that collagen 3 is seen in both thin, compacted lesions (42 days) as well as larger, 
less dense lesions (28 and 73-85 days). GFAP is predominantly observed at the lesion 
border. The white arrows indicate examples of structures of interest, and the white circles 
indicate examples of autofluorescence from hemosiderin. H&E scale bars (black) indicate 
50μm and fluorescent image scale bars (white) indicate 100μm. For additional details on 
the lesion location, see Figure IX in the Data Supplement. 
 
Figure 2. The lesion in chronic human ICH consists primarily of collagen 3. Each 
column corresponds to the indicated patient number (for additional case and location 
details, see the Table and Figure V in the Data Supplement). Each row is labeled by its 
corresponding marker. The top row provides an overview of the three chronic ICH 
lesions at low magnification followed by high magnification images that correspond to 
the dashed boxes. Elastic Van Gieson (eVG) staining at high magnification highlights (in 
pink) the extensive collagen found inside the lesions. Additional staining with collagen 3 
and 4 reveals that the lesion consists primarily of collagen 3. All unlabeled scale bars 
after the first row indicate 100μm.  
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Figure 2. The lesion in chronic human ICH consists primarily of collagen 3. Each 
column corresponds to the indicated patient number (for additional case and location 
details, see the Table and Figure S5 in the supplement). Each row is labeled by its 
corresponding marker. The top row provides an overview of the three chronic ICH 
lesions at low magnification followed by high magnification images that correspond to 
the dashed boxes. Van Gieson (eVG) staining at high magnification highlights (in pink) 
the extensive collagen found inside the lesions. Additional staining with collagen 3 and 4 
reveals that the lesion consists primarily of collagen 3. All unlabeled scale bars after the 
first row indicate 100μm.  
 
 
